The compounds as the estrogen related receptors modulators and the uses thereof

Details for Australian Patent Application No. 2009225171 (hide)

Owner Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences

Inventors Kang, Zhanfang; Zhou, Xi; Wong, Chiwai; Ding, Ke

Agent Adams Pluck

Pub. Number AU-A-2009225171

PCT Pub. Number WO2009/111943

Priority 200810026782.0 13.03.08 CN

Filing date 5 March 2009

Wipo publication date 17 September 2009

International Classifications

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 239/86 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/90 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

28 April 2011 Section 223 Application Received

  Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences An application to extend the time from 13 Oct 2010 to 13 Feb 2011 in which to enter National Phase has been filed . Address for service in Australia - Adams Pluck Suite 3, Level 1 20 George St Hornsby NSW 2077 Extensions of Time, Section 223 2011

16 June 2011 Section 223 Application Allowed

  Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences The time in which to enter National Phase has been extended to 13 Feb 2011. Address for service in Australia - Adams Pluck Suite 4, Level 3 20 George Street Hornsby NSW 2077 Extensions of Time, Section 223

23 June 2011 PCT application entered the National Phase

  PCT publication WO2009/111943 Priority application(s): WO2009/111943

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225189-Method of treating cancer using a neuropeptide Y 5R (NP Y5R) antagonist

2009225124-Prefabricated self-supporting construction element